PremiumZBIO

Zbio: surge following successful trial and CEO purchases

ZBIO stock jumps by 16% after a positive update on a drug trial for multiple sclerosis and significant CEO purchases.

By the SpyStocks desk · 6mo ago · 2 min read

Related Stories

Major move at Somnigroup International: CEO buys shares for almost $2 million one day after major deal completion

PremiumInsidersSGI9h ago3 min read

Will Pfizer do a Moderna for investors?

PremiumInsidersPFE1d ago4 min read

Intriguing activity in Madison Air

PremiumInsidersMAIR1d ago3 min read